SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Abgenix, Inc. (ABGX)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Icebrg who wrote (399)12/22/2004 4:17:14 PM
From: Icebrg   of 590
 
Form 8-K for ABGENIX INC

22-Dec-2004

Entry Material Agreement, Financial Obligation Matter, Financial Statements and Exhib

Item 1.01. Entry into a Material Definitive Agreement

On December 21, 2004, Abgenix, Inc., (the "Company"), closed its previously disclosed private placement of the Company's 1.75% Convertible Senior Notes due 2011 (the "Notes") in an aggregate principal amount of $300,000,000, including $75,000,000 representing the initial purchasers' exercise of their option to purchase additional Notes, to qualified institutional buyers pursuant to exemptions from the registration requirements of the Securities Act of 1933 (the "Act").
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext